Peter Borger says: "In addition, it was you who introduced a putative alternative metabolic route for vit C, or a long storage capacity of vit c in the liver. Both mechanism make the gene redundant, and that was my initial claim."
But, in conditions of insufficient dietary vitamin C, debility and dead can result. Therefore the gene is not redundant by any alternative genetic or biochemical processes. Therefore, why does not directed mutation correct the "stop" codon mutation and return the gene to activity in stress conditions?
"According to the hypothesis of 'non-random mutations and a multipurpose genome', redundant genes will be readily inactivated over time, since they are not under selective constraint. That's what we find in primates. Okay, the inactivation is in the same spot, but that may be due to non-random mutations, or if you like 'hot spot' mutations as they are called in literature."
But why is this a common hotspot in almost all of the primates but not all other mammals? Why does the same mutation occur at the "hotspot" in the primate GLO pseudogene? Are hotspots susceptible to repeated occurences of the same mutation? Why is the same common primate mutation not found throughout mammals if this is a hotspot susceptible to a particular nucleotide substitution?
I'm afraid your explanation of directed mutation for primate (and human) GLO pseudogenes instead of common ancestry is flimsy.
I don't think anyone will argue that all points on a gene have an equal likelihood of mutation. However you wish to extrapolate that this means that there is a directing mechanism which produces these unequal distributions of mutations. You then imply that this means an intelligent design of a multipurpose genome. But why doesn't your directing mechanism act on the multipurpose GLO genome in conditions of scurvy?